Feasibility trial success could mean a new therapy, but not for a few years yet.
The data are positive, but might not do much for the company’s sales.
Deal is the fifth largest robotics surgery purchase ever, and the second big move from Stryker.
Having succeeded with cystic fibrosis Vertex is now chasing a cure for type 1 diabetes.
Carmat says its artificial heart is the best such device in existence. But time is short, and so is money.
Before today’s trial readout no one was sure how remote ischaemic conditioning worked; now the investigators are pretty certain that it doesn’t.
Intuitive Surgical makes the most money per employee – but the title of “most improved” goes to Philips.
Software can be a medical device. Can it also be a drug?
Ablation company takes on a new tech, and responsibility for an expensive clinical trial.